Pirfenidone to Prevent Fibrosis in Ards.

PHASE3RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Respiratory Distress Syndrome (ARDS)
Interventions
DRUG

Pirfenidone

From days 1-7: 801mg/day; from days 8-14:1602mg/day, from day 15 to ICU discharge 2403 mg/day. All drugs will be delivered by a nasogastric tube divided in 3 daily doses.

DRUG

Placebo

All drugs will be delivered by a nasogastric tube divided in 3 daily doses.

Trial Locations (17)

10126

RECRUITING

AOU Città della Salute e della Scienza, Torino

15121

RECRUITING

Ospedale Cesare Arrigo, Alessandria

20070

RECRUITING

Ospedale Uboldo di Cernusco sul Naviglio, Milan

20132

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

25123

RECRUITING

ASST Spedali Civili di Brescia, Brescia

33100

RECRUITING

Azienda Sanitaria Universitaria Integrata di Udine, Udine

53100

RECRUITING

Azienda Ospedaliero Universitaria Senese, Siena

56126

RECRUITING

Azienda Ospedaliero Universitaria Pisana, Pisa

Unknown

RECRUITING

Ospedale Santa Maria, Bari

RECRUITING

Ospedale di Merano, Merano

RECRUITING

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

RECRUITING

AOU Policlinico Paolo Giaccone, Palermo

RECRUITING

AOU Pisana, Pisa

RECRUITING

A.O.R San Carlo, Potenza

09123

RECRUITING

Ospedale San Giovanni di Dio - Azienda Ospedaliera Universitaria di Cagliari, Cagliari

00133

RECRUITING

Fondazione PTV - Policlinico Tor Vergata, Rome

010000

RECRUITING

Astana Medical University, Astana

All Listed Sponsors
lead

Università Vita-Salute San Raffaele

OTHER